Biodexa Pharmaceuticals Ratios (2013-2025) | BDRX

Ratios Dec2013 Dec2014 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Sep2020 Dec2020 Jun2021 Sep2021 Dec2021 Jun2022 Sep2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Profitability
Gross Margin (Quarter)
EBT Margin (Quarter)
-4,749.13%-223,237.50%-293,375.00%-1,522.69%
EBIT Margin (Quarter)
-4,920.87%-229,312.50%-288,000.00%-806.48%
EBITDA Margin (Quarter)
-4,920.87%-229,312.50%-288,000.00%-806.48%
Operating Margin (Quarter)
-4,920.87%-229,312.50%-288,000.00%-806.48%
Net Margin (Quarter)
-411.74%-228,725.00%-216,812.50%-786.03%
FCF Margin (Quarter)
-1,974.35%-87,487.50%-87,487.50%47.13%
Efficiency
Inventory Average (Quarter)
1.21M1.30M1.08M
Assets Average (Quarter)
61.61M57.10M37.57M31.51M38.21M27.31M12.26M14.80M8.22M11.52M15.36M18.30M19.37M21.98M
Invested Capital (Quarter)
8.69M1.61M8.67M2.40M1.78M0.83M0.21M0.78M5.57M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
20.13116.68-833.8653.4620.7320.73157.42157.42192.9186.18-14.87
Debt Ratio (Quarter)
0.630.570.730.060.570.860.970.850.920.900.880.050.680.010.640.030.69
Times Interest Earned (Quarter)
20.13116.68-833.8653.4620.7320.73157.42157.42192.9186.18-14.87
Valuation
Enterprise Value (Quarter)
-17.53M-5.61M-3.01M-11.55M-14.05M-5.37M-9.96M-5.88M-13.56M-8.09M-3.33M-6.54M-7.41M-6.38M-2.14M-5.38M-11.35M
Return Ratios
Return on Sales (Quarter)
-0.04%-22.87%-30.08%-0.16%
Return on Capital Employed (Quarter)
-270.46%-298.21%-349.93%-513.99%-206.54%-157.97%
Return on Invested Capital (Quarter)
-0.08%-0.09%-0.31%-0.20%-0.26%-0.09%-0.25%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%-0.04%-0.01%-0.02%-0.03%-0.02%-0.01%-0.01%0.00%